Home › Companies › CYTEK BIOSCIENCES INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and CYTEK BIOSCIENCES INC.’s Form 8-K, filed June 11, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 5, 2024: 4 items on CYTEK BIOSCIENCES INC.’s Form 8-K, filed June 11, 2024: 2 elected · 2 approved.
Notable dissent: 1 director (13.4% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore CYTEK BIOSCIENCES INC. in the interactive database Compare manager voting policies
These tallies are CYTEK BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 11, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Wenbin Jiang, Ph.D. | 64,177,338 | -- | -- | 9,915,036 | 23,010,427 | 87% | Elected | — |
| Elect Director: Michael Holder | 70,298,785 | -- | -- | 3,793,589 | 23,010,427 | 95% | Elected | — |
| 2. Executive Compensation. On an advisory basis, compensation paid to the Company's named executive officers for the year ended December 31, 2023 | 63,537,386 | 10,476,039 | 78,949 | -- | 23,010,427 | 86% | Approved | — |
| 3. Ratification of the Selection of Independent Registered Public Accounting Firm. The selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 | 94,116,564 | 2,329,549 | 656,688 | -- | -- | 98% | Approved | — |
Source: CYTEK BIOSCIENCES INC., Form 8-K, filed with the SEC on June 11, 2024 — read the filing on EDGAR.
See voting trends for Industrials companies, 2023-2024: shareholder support by sector and by company size.
164 asset managers disclosed a vote on at least one CYTEK BIOSCIENCES INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: To elect each of our two Class III director nominees to our Board of Directors for a three-year term, to hold office until our 2027 annual meeting of stockholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal: Michael Holder
CYTEK BIOSCIENCES INC.’s own tally for this item (“Elect Director: Michael Holder”): 70,298,785 for, 3,793,589 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Each of the following nominees was elected to serve as a Class III director, to hold office until the Company's 2027 annual meeting of stockholders and until his successor has been duly elected and qualified or until his earlier death, resignation or removal:”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 33,376,751 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,709,204 | 0 | 0 | 0 | For |
| BlackRock | 8,025,009 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 4,548,308 | 0 | 0 | 0 | For |
| Fidelity | 2,040,715 | 0 | 0 | 0 | For |
| State Street | 1,099,201 | 0 | 0 | 0 | For |
| Charles Schwab | 846,176 | 0 | 0 | 0 | For |
| Dimensional | 798,981 | 0 | 0 | 0 | For |
| Hartford | 552,629 | 0 | 0 | 0 | For |
| Northwestern Mutual | 355,511 | 0 | 0 | 0 | For |
| Nationwide | 325,645 | 0 | 0 | 0 | For |
| TIAA | 302,499 | 0 | 0 | 0 | For |
| Equitable | 284,670 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 268,350 | 0 | 0 | 0 | For |
| First Trust | 248,017 | 0 | 0 | 0 | For |
| Jackson National | 227,535 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 211,217 | 0 | 0 | 0 | For |
| Invesco | 163,969 | 0 | 0 | 0 | For |
| American Century | 127,666 | 0 | 0 | 0 | For |
| Principal | 115,655 | 0 | 0 | 0 | For |
| Lincoln Financial | 111,676 | 0 | 0 | 0 | For |
| Prudential/PGIM | 103,207 | 0 | 0 | 0 | For |
| BNY Mellon | 90,513 | 0 | 0 | 0 | For |
| Thrivent | 84,989 | 0 | 0 | 0 | For |
| Empower | 73,155 | 0 | 0 | 0 | For |
| Catholic Responsible Investments Funds | 59,542 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Description as filed by funds: To elect each of our two Class III director nominees to our Board of Directors for a three-year term, to hold office until our 2027 annual meeting of stockholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal: Wenbin Jiang, Ph.D.
CYTEK BIOSCIENCES INC.’s own tally for this item (“Elect Director: Wenbin Jiang, Ph.D.”): 64,177,338 for, 9,915,036 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Each of the following nominees was elected to serve as a Class III director, to hold office until the Company's 2027 annual meeting of stockholders and until his successor has been duly elected and qualified or until his earlier death, resignation or removal:”
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 31,520,972 for, 1,773,549 withheld, 82,230 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,709,204 | 0 | 0 | 0 | For |
| BlackRock | 8,025,009 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 4,548,308 | 0 | 0 | 0 | For |
| Fidelity | 2,040,715 | 0 | 0 | 0 | For |
| State Street | 1,086,550 | 0 | 0 | 12,651 | For |
| Charles Schwab | 846,176 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 798,981 | Withhold |
| Hartford | 552,629 | 0 | 0 | 0 | For |
| Northwestern Mutual | 355,511 | 0 | 0 | 0 | For |
| Nationwide | 302,021 | 0 | 0 | 23,624 | Mixed |
| TIAA | 302,499 | 0 | 0 | 0 | For |
| Equitable | 284,670 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 268,350 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 0 | 248,017 | Withhold |
| Jackson National | 217,274 | 0 | 10,261 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 211,217 | 0 | 0 | 0 | For |
| Invesco | 163,969 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 127,666 | Withhold |
| Principal | 0 | 0 | 0 | 115,655 | Withhold |
| Lincoln Financial | 102,400 | 0 | 0 | 9,276 | Mixed |
| Prudential/PGIM | 103,207 | 0 | 0 | 0 | For |
| BNY Mellon | 90,513 | 0 | 0 | 0 | For |
| Thrivent | 0 | 0 | 0 | 84,989 | Withhold |
| Empower | 0 | 0 | 0 | 73,155 | Withhold |
| Catholic Responsible Investments Funds | 0 | 0 | 0 | 59,542 | Withhold |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
86% Approved · of votes cast
Prior year: 97.6% for (June 14, 2023 meeting) ▼ 11.8 pts
Description as filed by funds: To vote, on an advisory basis, regarding the compensation of our named executive officers for the year ended December 31, 2023.
CYTEK BIOSCIENCES INC.’s own tally for this item (“2. Executive Compensation. On an advisory basis, compensation paid to the Company's named executive officers for the year ended December 31, 2023”): 63,537,386 for, 10,476,039 against — passed, per its Form 8-K filed June 11, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “On an advisory basis, compensation paid to the Company's named executive officers for the year ended December 31, 2023 was approved based on the following results of voting:”
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,709,204 | 0 | 0 | 0 | For |
| BlackRock | 8,025,009 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 0 | 4,548,308 | 0 | 0 | Against |
| Fidelity | 2,040,715 | 0 | 0 | 0 | For |
| State Street | 1,095,681 | 3,520 | 0 | 0 | For |
| Charles Schwab | 846,176 | 0 | 0 | 0 | For |
| Dimensional | 798,981 | 0 | 0 | 0 | For |
| Hartford | 552,629 | 0 | 0 | 0 | For |
| Northwestern Mutual | 355,511 | 0 | 0 | 0 | For |
| Nationwide | 25,462 | 300,183 | 0 | 0 | Mixed |
| TIAA | 302,499 | 0 | 0 | 0 | For |
| Equitable | 284,670 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 268,350 | 0 | 0 | 0 | For |
| First Trust | 248,017 | 0 | 0 | 0 | For |
| Jackson National | 227,535 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 211,217 | 0 | 0 | 0 | For |
| Invesco | 0 | 163,969 | 0 | 0 | Against |
| American Century | 0 | 127,666 | 0 | 0 | Against |
| Principal | 115,655 | 0 | 0 | 0 | For |
| Lincoln Financial | 111,676 | 0 | 0 | 0 | For |
| Prudential/PGIM | 103,207 | 0 | 0 | 0 | For |
| BNY Mellon | 90,513 | 0 | 0 | 0 | For |
| Thrivent | 84,989 | 0 | 0 | 0 | For |
| Empower | 0 | 73,155 | 0 | 0 | Against |
| Catholic Responsible Investments Funds | 0 | 59,542 | 0 | 0 | Against |
Fund voting reports, all 56 managers: 28,046,073 for, 5,334,909 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. | 6,657,030 | 0 | 0 | 0 | For |
| BROWN CAPITAL MANAGEMENT LLC | 0 | 6,372,032 | 0 | 0 | Against |
| RA CAPITAL MANAGEMENT, L.P. | 3,870,043 | 0 | 0 | 0 | For |
| State Street | 3,133,449 | 37,239 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 2,947,986 | 0 | 0 | 0 | For |
| BlackRock | 2,401,901 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,130,438 | 0 | 0 | 0 | For |
| Wellington | 1,255,937 | 0 | 0 | 0 | For |
| Charles Schwab | 900,180 | 0 | 0 | 0 | For |
| Northern Trust | 808,481 | 81 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 647,784 | 0 | 0 | 0 | For |
| Impresa Management LLC | 517,790 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 516,466 | 0 | 0 | 0 | For |
| Vanguard | 315,760 | 0 | 0 | 0 | For |
| Nuveen | 305,665 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 255,163 | 0 | 0 | Against |
| Invesco | 0 | 205,978 | 0 | 0 | Against |
| STATE OF WISCONSIN INVESTMENT BOARD | 195,392 | 0 | 0 | 0 | For |
| Legal & General Investment Management America Inc | 0 | 190,161 | 0 | 0 | Against |
| Connor, Clark & Lunn Investment Management Ltd. | 169,819 | 0 | 0 | 0 | For |
| Rhumbline | 156,147 | 3,949 | 0 | 0 | For |
| Goldman Sachs | 158,972 | 0 | 0 | 0 | For |
| UBS | 0 | 143,518 | 0 | 0 | Against |
| American Century | 0 | 127,666 | 0 | 0 | Against |
| Prudential/PGIM | 112,232 | 0 | 0 | 0 | For |
Institutional-manager reports, all 127 managers: 28,493,948 for, 7,614,117 against, 184 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
98% Approved · of votes cast
Prior year: 100.0% for (June 14, 2023 meeting) ▼ 2.4 pts
Description as filed by funds: To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
CYTEK BIOSCIENCES INC.’s own tally for this item (“3. Ratification of the Selection of Independent Registered Public Accounting Firm. The selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December”): 94,116,564 for, 2,329,549 against — passed, per its Form 8-K filed June 11, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified based on the following results of voting:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 33,321,640 for, 59,542 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,709,204 | 0 | 0 | 0 | For |
| BlackRock | 8,025,009 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 4,548,308 | 0 | 0 | 0 | For |
| Fidelity | 2,040,715 | 0 | 0 | 0 | For |
| State Street | 1,099,201 | 0 | 0 | 0 | For |
| Charles Schwab | 846,176 | 0 | 0 | 0 | For |
| Dimensional | 798,981 | 0 | 0 | 0 | For |
| Hartford | 552,629 | 0 | 0 | 0 | For |
| Northwestern Mutual | 355,511 | 0 | 0 | 0 | For |
| Nationwide | 325,645 | 0 | 0 | 0 | For |
| TIAA | 302,499 | 0 | 0 | 0 | For |
| Equitable | 284,670 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 268,350 | 0 | 0 | 0 | For |
| First Trust | 248,017 | 0 | 0 | 0 | For |
| Jackson National | 227,535 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 211,217 | 0 | 0 | 0 | For |
| Invesco | 163,969 | 0 | 0 | 0 | For |
| American Century | 127,666 | 0 | 0 | 0 | For |
| Principal | 115,655 | 0 | 0 | 0 | For |
| Lincoln Financial | 111,676 | 0 | 0 | 0 | For |
| Prudential/PGIM | 103,207 | 0 | 0 | 0 | For |
| BNY Mellon | 90,513 | 0 | 0 | 0 | For |
| Thrivent | 84,989 | 0 | 0 | 0 | For |
| Empower | 73,155 | 0 | 0 | 0 | For |
| Catholic Responsible Investments Funds | 0 | 59,542 | 0 | 0 | Against |
Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 131,272,929 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 8.92% |
| 2 | BlackRock | 6.11% |
| 3 | Brown Capital Management Mutual Funds | 3.46% |
| 4 | Fidelity | 1.55% |
| 5 | State Street | 0.84% |
| 6 | Charles Schwab | 0.64% |
| 7 | Dimensional | 0.61% |
| 8 | Hartford | 0.42% |
| 9 | Northwestern Mutual | 0.27% |
| 10 | Nationwide | 0.25% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | HHLR ADVISORS, LTD. | 5.07% |
| 2 | BROWN CAPITAL MANAGEMENT LLC | 4.85% |
| 3 | RA CAPITAL MANAGEMENT, L.P. | 2.95% |
| 4 | State Street | 2.42% |
| 5 | NEW YORK STATE COMMON RETIREMENT FUND | 2.25% |
| 6 | BlackRock | 1.83% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.62% |
| 8 | Wellington | 0.96% |
| 9 | Charles Schwab | 0.69% |
| 10 | Northern Trust | 0.62% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Entities affiliated with BlackRock, Inc. | 17,779,753 | 13.54% | Proxy statement (DEF 14A), proxy filed April 25, 2024 |
| BlackRock | 16,547,693 | 12.61% | Form 13F, quarter ended March 31, 2024 |
| Entities affiliated with Brown Capital | 12,016,325 | 9.15% | Proxy statement (DEF 14A), proxy filed April 25, 2024 |
| Entities affiliated with The Vanguard Group | 11,890,700 | 9.06% | Proxy statement (DEF 14A), proxy filed April 25, 2024 |
| Vanguard Group | 6,933,504 | 5.28% | Form 13F, quarter ended March 31, 2024 |
| Entities affiliated with RA Capital Management | 6,809,404 | 5.19% | Proxy statement (DEF 14A), proxy filed April 25, 2024 |
| Entities affiliated with HHLR Advisors, Ltd. | 6,657,030 | 5.07% | Proxy statement (DEF 14A), proxy filed April 25, 2024 |
| Ming Yan | 6,203,867 | 4.73% | Schedule 13G, filed February 14, 2024 |
| Wenbin Jiang | 5,702,130 | 4.34% | Schedule 13G, filed February 14, 2024 |
| State Street | 4,115,859 | 3.14% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 131,272,929 shares outstanding, as reported by CYTEK BIOSCIENCES INC. on its Form 10-Q dated April 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At CYTEK BIOSCIENCES INC.'s shareholder meeting held June 5, 2024, in the 2023-2024 proxy season, 164 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 841 separate fund positions. On the most widely held item on that ballot — To vote, on an advisory basis, regarding the compensation of our named executive officers for… — CYTEK BIOSCIENCES INC.'s filing reports the proposal as approved, with 86% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CYTEK BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 11, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CYTEK BIOSCIENCES INC.’s 10-Q dated April 30, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
CYTEK BIOSCIENCES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “CYTEK BIOSCIENCES (CTKB) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/cytek-biosciences-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.